Rituximab and Trastuzumab IV Infusion Vials
The framework is for the supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to health boards across NHSScotland
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value
£11,000,000
Published
20 Feb 2020
Closes
23 Mar 2020
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Rituximab IV Infusion Vials
£8,500,000
This Framework Agreement is for the supply of rituximab 100mg and 500mg intravenous infusion vials to NHSScotland. The Authority intends to award this Lot as an unranked multi-supplier framework per line to and envisaged maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: United Kingdom
Lot 2 Trastuzumab IV Infusion Vials
£25,000,000
This Framework Agreement is for the supply of trastuzumab 100mg and 440mg intravenous infusion vials to NHSScotland. The Authority intends to award this Lot as an unranked multi-supplier framework per line to and envisaged maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Delivery: United Kingdom
Documents
Unlock document linkRituximab and Trastuzumab IV Infusion Vials
Not provided
The framework is for the supply of rituximab intravenous infusion vials and trastuzumab intravenous infusion vials to health boards across NHSScotland
Contract notice · Web page
Rituximab and Trastuzumab IV Infusion Vials
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.